#MRNS #BULLISH, COULD BE RISKY BUT SO IS EVERYTHING Pembelian
Marinus Pharmaceuticals, Inc.NASDAQ
Deskripsi
⋅ 1)OVERSOLD
2) GOOD RISK TO REWARD RATIO
3) EARNINGS IN 4 WEEKS
Can also go bearish due to older bad news but high potentially for it to boost.
#4 follow for more analysis.